Full Member
Gail Louw
Membership since:
2025
Field of activity:
Other Memberships/Affiliations
SAWISE
Degrees:
2009
Doctorate Medical and Health Sciences incl Neurosciences
2003
Undergraduate Biological Systems and Organisms
2004
Master Biological Systems and Organisms
Publications resulting from Research
• Rabia Johnson, Elizabeth M Streicher, Gail E Louw; Robin M Warren, Paul D Van Helden, Thomas C Victor. Mycobacterium: Molecular Biology; Chapter 5: Drug resistance in Mycobacterium Tuberculosis, 2005.
• GE Louw, RM Warren, PR Donald, MB Murray, M Bosman, PD Van Helden, DB Young, TC Victor. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis, 2006. 10(7): p. 802-7
• Rabia Johnson, Elizabeth M. Streicher, Gail E. Louw, Robin M. Warren, Paul D. van Helden, Thomas C. Victor. Drug Resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 8: 97–112. 2006.
• Gail E. Louw, Robin M. Warren, Paul D. van Helden, Thomas C. Victor. Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis. Clin Chem Lab Med, 2009. 47(4): p. 500-1
• G.E. Louw; R. M. Warren, N.C. Gey van Pittius, C.R.E. McEvoy, P.D. van Helden; T.C. Victor. A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance. Antimicrob Agents Chemother, 2009. 53(8): p. 3181-9
• Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Pando RH, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC. Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin Resistant Mycobacterium tuberculosis through efflux. Am J Respir Crit Care Med. 2011 Jul 15;184(2):269-76.
• Black PA, Warren RM, Louw GE, van Helden PD, Victor TC, Kana BD. Energy metabolism and drug efflux in Mycobacterium tuberculosis. Antimicrobial agents and Chemother, 2014. May; 58 (5):2491-503
• Black PA, de Vos M, Louw GE, van der Merwe RG, Dippenaar A, Streicher EM, Abdallah AM, Sampson SL, Victor TC, Dolby T, Simpson JA, van Helden PD, Warren RM, Pain A. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates. BMC Genomics. 2015 Oct 24;16(1):857
• Pule, Caroline; Sampson, Samantha; Warren, Rob; Black, Philippa; Van Helden, Paul; Victor, Tommie; Louw, Gail. Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J Antimicrob Chemother. 2016 Jan;71(1):17-26. Epub 2015 Oct 15.
• Gail E Louw, Samantha L Sampson. Chapter 10: Implications of Chromosomal Mutations for Mycobacterial Drug Resistance Book: Drug resistance in Bacteria, Fungi, Malaria and cancer. Springer International Publishing Switzerland. 2017
• GE Louw, RM Warren, PR Donald, MB Murray, M Bosman, PD Van Helden, DB Young, TC Victor. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis, 2006. 10(7): p. 802-7
• Rabia Johnson, Elizabeth M. Streicher, Gail E. Louw, Robin M. Warren, Paul D. van Helden, Thomas C. Victor. Drug Resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. 8: 97–112. 2006.
• Gail E. Louw, Robin M. Warren, Paul D. van Helden, Thomas C. Victor. Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis. Clin Chem Lab Med, 2009. 47(4): p. 500-1
• G.E. Louw; R. M. Warren, N.C. Gey van Pittius, C.R.E. McEvoy, P.D. van Helden; T.C. Victor. A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance. Antimicrob Agents Chemother, 2009. 53(8): p. 3181-9
• Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Pando RH, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC. Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin Resistant Mycobacterium tuberculosis through efflux. Am J Respir Crit Care Med. 2011 Jul 15;184(2):269-76.
• Black PA, Warren RM, Louw GE, van Helden PD, Victor TC, Kana BD. Energy metabolism and drug efflux in Mycobacterium tuberculosis. Antimicrobial agents and Chemother, 2014. May; 58 (5):2491-503
• Black PA, de Vos M, Louw GE, van der Merwe RG, Dippenaar A, Streicher EM, Abdallah AM, Sampson SL, Victor TC, Dolby T, Simpson JA, van Helden PD, Warren RM, Pain A. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates. BMC Genomics. 2015 Oct 24;16(1):857
• Pule, Caroline; Sampson, Samantha; Warren, Rob; Black, Philippa; Van Helden, Paul; Victor, Tommie; Louw, Gail. Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J Antimicrob Chemother. 2016 Jan;71(1):17-26. Epub 2015 Oct 15.
• Gail E Louw, Samantha L Sampson. Chapter 10: Implications of Chromosomal Mutations for Mycobacterial Drug Resistance Book: Drug resistance in Bacteria, Fungi, Malaria and cancer. Springer International Publishing Switzerland. 2017
Gordon Research conference: Tuberculosis Drug discovery and development: Challenges, advances and future prospects in the fight against tuberculosis.
2025
Girona, SpainAmerican Society for Microbiology, 115th General Meeting
2025
New Orleans, LA, USAKeystone conference on Drug Resistance and Persistence
2025
Kampla, Uganda8th International conference on the pathogenesis of mycobacterial infection
2025
Stockholm, SwedenANNUAL ACADEMIC YEARDAY
2025
Cape Town, South AfricaAmerican Society for Microbiology, General meeting
2025
San Diego, CA, USAMRC TB COLLOQUIUM
2025
Cape Town, South AfricaKEYSTONE SYMPOSIUM (OVERCOMING THE CRISIS OF TB AND HIV)
2025
Arusha, TanzaniaINFECTIOUS DISEASES SYMPOSIUM
2025
Cape Town, South Africa38th Union World Conference on Lung Health
2025
Cape Town, South Africa48th ANNUAL ACADEMIC YEAR DAY
2025
Cape Town, South AfricaSWISS/SA Bioinformatics Workshop: Databases and Metabolic modelling course.
2025
Cape Town, South AfricaSET Supervision Workshop
2025
Stellenbosch, South AfricaDesign and Interpretation of Clinical trials (online)
2025
Johns Hopkins University, USA (Online)Epidemiology: The Basic Science of Public Health (online)
2025
University of North Carolina (Online)Epidemics – the Dynamics of Infectious diseases (online)
2025
Pennsylvania State University, USA (Online)Global Tuberculosis Clinical Management and Research (online)
2025
John's Hopkins University, USA (Online)Introduction to lab safety
2025
NIH, Bethesda, USAWorking Safely with HIV and other bloodborne pathogens for non-Hospital Personnel
2025
NIH, Bethesda, USALab safety at NIH
2025
NIH, Bethesda, USABrowsing genes and genomes with ENSEMBLE
2025
Harvard Medical School, Boston, USAUCSC Genome Browser
2025
Harvard Medical School, Boston, USABlast Tips and Tricks
2025
Harvard Medical School, Boston, USAXDR-TB conference 2017
2025
Cape Town, South AfricaSwiss/SA symposium in pathogen genomics
2025
Cape Town, South AfricaGordon Research conference: Tuberculosis Drug discovery and development
2025
Girona, SpainAmerican Society for Microbiology, 115th General Meeting
2025
New Orleans, LA, USAKeystone conference on Drug Resistance and Persistence
2025
Kampala, Uganda8th International conference on the pathogenesis of mycobacterial infections
2025
Stockholm, SwedenKEYSTONE SYMPOSIUM (OVERCOMING THE CRISIS OF TB AND HIV)
2025
Arusha, Tanzania